Scottish Health Innovations Ltd

Ambicare_lo_res_small_19.10.2009

AMBULIGHT PDT RECEIVES CE MARK APPROVAL AHEAD OF EUROPEAN LAUNCH

The world’s first light emitting sticking plaster for the treatment of skin cancer
Ambicare, a leading developer of ambulatory light sources for medical and consumer healthcare applications today announces that it has received CE Mark approval to market its lead product, Ambulight PDT, in Europe.  Photodynamic Therapy and Phototherapy are leading treatments for many skin conditions.

Read more.....
 

Stay Informed

If you would like to keep up to date with what is happening in SHIL then sign up for our newsletter here.